tiprankstipranks
Trending News
More News >
Galectin Therapeutics (GALT) (GALT)
:GALT
US Market
Advertisement

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

Compare
633 Followers

Galectin Therapeutics (GALT) Ownership Overview

19.65%4.58%2.87%3.34%69.56%
19.65% Insiders
2.87% Other Institutional Investors
3.34% ETFs
69.56% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 10.79% of the company’s stock is owned by Institutional Investors, 19.65% is owned by Insiders, and 69.56% is owned by Public Companies and Individual Investors.
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 7.46% of the company’s stock is owned by Institutional Investors, 19.65% is owned by Insiders, and 3.34% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 22, 2025
xxxxxxxxxxxxx
$2920
Jul 18, 2025
xxxxxxxxxxxxx
$14450
Dec 31, 2024
xxxxxxxxxxxxx
$7540
Dec 26, 2024
xxxxxxxxxxxxx
$11045

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,328,981Insider16.12%55,466,628
2,102,263Institution3.28%11,289,152
1,898,844Institution2.96%10,196,792
1,045,541Insider1.63%5,614,555
834,592Insider1.30%4,481,759
495,038Institution0.77%2,658,354
163,436Institution0.26%877,651
147,832Insider0.23%793,858
105,431Institution0.16%566,164
79,345Institution0.12%426,083

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,102,263Institution3.28%11,289,152
495,038Institution0.77%2,658,354
163,436Institution0.26%877,651
54,024Institution0.08%290,109
37,318Institution0.06%200,398
27,623Institution0.04%148,336
26,902Institution0.04%144,464
22,913Institution0.04%123,043
3,725Institution<0.01%20,003
1,787Institution<0.01%9,596

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,355,732Institution2.12%4,934,864
543,112Institution0.85%1,976,928
105,431Institution0.16%566,164
79,345Institution0.12%471,309
53,742Institution0.08%319,227

FAQ

Who Owns Galectin Therapeutics (GALT) (GALT)?
According to the latest TipRanks data, approximately 2.87% of the company's stock is held by institutional investors, 19.65% is held by insiders, and 69.56% is held by retail investors.
    What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.87% of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 69.56% of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics (GALT) (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics (GALT) (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis